Ganesh Fund

Fund Purpose - Removing Obstacles in Canine Cancer Drug Discovery & Development

The Ganesh Fund supports administering investigational drugs for supporting essential care, blood work, and imaging related to drug discovery and development.

Founding Statement

The Ganesh Fund was established in 2026 in honor of Ganesh Levine, an eight-year-old Anatolian Shepherd living with a rare and aggressive cancer. Ganesh's diagnosis, and the complexity of his disease, highlighted a critical gap in oncology research and clinical care. Targeted treatments are limited and the patients who need those therapies — dogs and humans alike — cannot wait. Certain cancers share underlying biology across species. For these cancers, dogs and humans can develop strikingly similar diseases, making canine oncology a valuable model in translational medicine. Discoveries made in dogs can help inform and accelerate the development of therapeutics for humans.

The Ganesh Fund was created with a clear and urgent purpose: to fund cancer drug discovery and development — advancing targeted immunotherapies with the potential to fundamentally change outcomes for dogs with aggressive cancers. This work is being conducted at the Center for Companion Animal Health, UC Davis School of Veterinary Medicine, the number one veterinary school in the country. It is our hope that our work will help save other dogs in the future who receive the same devastating diagnosis as our Ganesh — giving them options for life-saving treatments and cures.

Ganesh's Story

Ganesh Levine was a gentle giant with a loving, steadfast and loyal nature. He lived for a remarkable 2.5 years with his metastatic cancer. His diagnosis was met with the full resources of veterinary precision medicine as well as integrative medicine. Together with his care team, we pursued every available avenue on his behalf. Ganesh lived his life believing that every day was a happy day. He fought hard until the very end but ultimately his survival was limited by the small number of targeted drugs available. For many aggressive cancers like his, effective treatments don’t last very long and options run out too soon. With your help, the Ganesh Fund will accelerate the development of these targeted cancer drugs — so that the next dog who receives Ganesh's diagnosis has an even better chance of long-term survival.

Case for Support

Federal and pharmaceutical funding follows established pathways and rarely reaches the early-stage, cross-species research that the Ganesh Fund prioritizes. Donor investment fills this gap at the moment where it has the greatest leverage — before the discoveries are made, not after. Ganesh was one very special dog. But every year, thousands of dogs receive similar diagnoses. This fund is built on the belief that our companion animals deserve better, and that the science to deliver better is within our reach.

Join us. Support the Ganesh Fund today.